Marshall Wace’s Signify Health, Inc. SGFY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-257,131
Closed -$7.5M 3655
2022
Q3
$7.5M Buy
257,131
+217,792
+554% +$5.02M 0.02% 1087
2022
Q2
$542K Sell
39,339
-354,487
-90% -$4.99M ﹤0.01% 2753
2022
Q1
$7.15M Sell
393,826
-8,008
-2% -$115K 0.01% 1124
2021
Q4
$5.71M Buy
+401,834
New +$6.22M 0.01% 1263
2021
Q3
Sell
-10,334
Closed -$314K 3576
2021
Q2
$314K Buy
10,334
+2,943
+40% +$80.9K ﹤0.01% 2309
2021
Q1
$216K Buy
+7,391
New +$229K ﹤0.01% 2236

Other funds holding SGFY

Marshall Wace's SGFY Position: Q4 2022 in Review

Marshall Wace sold out of Signify Health, Inc. (SGFY) in Q4 2022, closing a stake of 257,131 shares — an estimated $7.5M sold.

Marshall Wace first reported a position in SGFY in Q1 2021 and held it in 6 quarters. The position peaked at $7.5M in Q3 2022. 205 funds tracked by Wall St. Rank hold SGFY as of Q4 2022.

  • Marshall Wace reported no remaining Signify Health, Inc. position as of Q4 2022 after selling out during the quarter.
  • Marshall Wace sold 257,131 Signify Health, Inc. shares in Q4 2022, an estimated $7.5M.
  • Marshall Wace first reported a position in Signify Health, Inc. in Q1 2021 and held it in 6 quarters.
  • Marshall Wace's Signify Health, Inc. position peaked at $7.5M in Q3 2022.
  • 205 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q4 2022.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.